The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-amino-N-cyclopropyl-2-(4-(3-(2,6-dichloro-4-methylphenoxy)propyl)benzyl)-N-(2,3-dichlorobenzyl)propanamide ID: ALA1092186
PubChem CID: 15981115
Max Phase: Preclinical
Molecular Formula: C30H32Cl4N2O2
Molecular Weight: 594.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(Cl)c(OCCCc2ccc(CC(CN)C(=O)N(Cc3cccc(Cl)c3Cl)C3CC3)cc2)c(Cl)c1
Standard InChI: InChI=1S/C30H32Cl4N2O2/c1-19-14-26(32)29(27(33)15-19)38-13-3-4-20-7-9-21(10-8-20)16-23(17-35)30(37)36(24-11-12-24)18-22-5-2-6-25(31)28(22)34/h2,5-10,14-15,23-24H,3-4,11-13,16-18,35H2,1H3
Standard InChI Key: HHFNUPNPOFOJPD-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 41 0 0 0 0 0 0 0 0999 V2000
-4.6765 0.7837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6779 -0.0438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9603 -0.4567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2455 -0.0433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2487 0.7878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9623 1.1966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9649 2.0216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2538 2.4364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5353 2.0217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8240 2.4365 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.1055 2.0264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1049 1.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3919 0.7942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3204 1.2090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3147 2.0387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3989 2.4447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4060 3.2696 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.8214 0.7905 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-3.9605 -1.2817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2481 -1.6944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5308 -1.2822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8183 -1.6948 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5305 -0.4572 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.8185 -2.5198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1056 -1.2825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3885 -1.6952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3928 -2.5175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3187 -2.9301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0371 -2.5177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0343 -1.6879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3176 -1.2795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3129 -0.4545 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.7455 -1.2775 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-2.2273 -3.2378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4023 -3.2381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2483 -2.5194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9610 -2.9317 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0395 0.7999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8 9 1 0
3 19 1 0
4 5 1 0
19 20 1 0
9 10 1 0
20 21 1 0
2 3 1 0
21 22 1 0
10 11 1 0
21 23 2 0
5 6 2 0
22 24 1 0
11 12 2 0
22 25 1 0
6 1 1 0
25 26 1 0
12 13 1 0
26 27 2 0
1 2 2 0
27 28 1 0
13 14 2 0
28 29 2 0
6 7 1 0
29 30 1 0
14 15 1 0
30 31 2 0
31 26 1 0
3 4 2 0
31 32 1 0
15 16 2 0
30 33 1 0
34 24 1 0
35 34 1 0
24 35 1 0
16 11 1 0
7 8 1 0
16 17 1 0
20 36 1 0
36 37 1 0
12 18 1 0
14 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 594.41Molecular Weight (Monoisotopic): 592.1218AlogP: 7.93#Rotatable Bonds: 12Polar Surface Area: 55.56Molecular Species: BASEHBA: 3HBD: 1#RO5 Violations: 2HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 8.97CX LogP: 8.27CX LogD: 6.70Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.22Np Likeness Score: -0.90
References 1. Chen A, Bayly C, Bezençon O, Richard-Bildstein S, Dubé D, Dubé L, Gagné S, Gallant M, Gaudreault M, Grimm E, Houle R, Lacombe P, Laliberté S, Lévesque JF, Liu S, MacDonald D, Mackay B, Martin D, McKay D, Powell D, Remen L, Soisson S, Toulmond S.. (2010) Design and optimization of a substituted amino propanamide series of renin inhibitors for the treatment of hypertension., 20 (7): [PMID:20206513 ] [10.1016/j.bmcl.2010.02.036 ]